TP53 signature diagnostic system using multiplex reverse transcription-polymerase chain reaction system enables prediction of prognosis of breast cancer patients.

Shin TakahashiTakafumi FukuiTadashi NomizuYoichiro KakugawaFumisyoshi FujishimaTakanori IshidaNoriaki Ohuchi Chikashi Ishioka

Published in: Breast cancer (Tokyo, Japan) (2021)

This simple and precise diagnostic system to determine TP53 signature status may help in prognostic assessment, therapeutic decision-making, and treatment optimization in patients with breast cancer.

Keyphrases

decision making
transcription factor
combination therapy
real time pcr
smoking cessation